Technology Assessment
10-17-01

Definition – the process that examines the available evidence to form a conclusion as to the merits or role of a particular technology in relation to its possible use, purchase or reimbursement in current medical practice.

It should include efforts to assess the safety, effectiveness, efficiency and appropriateness of devices, medical and surgical procedures, and pharmaceuticals promoted as improving a patient’s condition or quality of life.

Considers these in regards to maximizing quality – the most effective health care services that medical science can provide.

Also includes the assessment of costs to determine whether equipment is appropriate and excluding any that does not provide any benefit to the patient and promoting that which does.

Claims of superiority should be investigated to assure that appropriate experimental testing has been completed to uphold manufacturer’s claims, or those claims of health care scientists in improving the treatments.

Categories of technology:

1. Devices


 

2. Procedures


 

3. Pharmaceuticals

Technology Life Cycle
  • Investigation – laboratory and clinical studies to discover or create, refine and package a new diagnostic or treatment modality.
  • Promotion – introducing the technology into the buying community.
  • Acceptance and utilization – incorporating the technology into practice.
  • Decline – as the technology is increasingly supplanted by superior new technology.
  • Obsolescence – when the new technology is obsolete and no longer appropriate.

  •  

     
     
     

    Targeting Technologies for Assessment

    As recommended by the Council on Health Care Technology of the Institute of Medicine, selection criteria should include:

    Other organizations involved include HCFA, NIH, National Institutes of Health Office of Medical Applications and Research.

    Essentially, these look at 3 components:

    1. High Utilization

    2. High Potential for Harm 3. High Cost – payers may be unwilling to pay form some technological procedures or diagnoses.
     

    How Technology Assessment is Performed

    1. Literature Review and Synthesis – review of primary medical literature is a requirement for every evaluation effort.

    2. Consensus Panels – experts review testimony from the scientific literature and seek input from consumers and medical professionals. 3. Meta-Analyses – summarizes the treatment effect obtained from a comprehensive determination of the pool of available published studies. This compares the findings and methodologies for similarities. Takes the information and pools it into statistical analyses.

    4. Outcomes Assessment – compares the performance of a technology against standards established or recommended by expert bodies.

    5. Randomized Clinical Trials – focused randomized, controlled, clinical trials are the "gold standard" of assessment. Should include "blinding" of physicians and patients regarding treatment assignment (double blind), hard end points not susceptible to other treatments, and other assessment factors pertinent to the methodology used in the study.

    Agencies Conducting Technology Assessment

  • U.S. FDA
  • Agency for Health Care Policy and Research (DHHS)
  • American College of Physicians
  • American Medical Assn.
  • Blue Cross and Blue Shield
  • ECRI
  • Office of Health Technology Assessment
  • Office of Technology Assessment
  • University Hospital Consortium

  •  

     

    Problems in Performing Technology Assessment

  • Lack of Evidence (not enough literature or patients to study, or poorly conducted research)
  • Lack of Agreement on How to Perform the Assessment (may lead to different results using different techniques)
  • Inconsistent Evidence (may result from different or inconsistent research methods)
  • Legal Interference (can be influenced from biased resources)
  • Breadth of Topics (difficult to successfully study or assess all technologies)
  • New Information (assessment process must be ongoing to adequately compare new uses)
  • Technology and Health Care Reform

  •  

     

    Ever-changing technology contributes to the turbulence or "white water change" of health care. While technology has contributed to greater success in diagnosis and treatment of diseases, it has also contributed to the rapid growth of health care expenditures.

    Higher rate of technology has also resulted by an increase in the specialty professions of physicians who are likely to use the tools available to them to perform the greatest maximum of health care services. But at what cost?

    The challenge for health care organizations and professionals will be how to control the effective use of this technology.

    Clinical decisions and protocols are likely to be developed as to what types of patients will warrant use of high cost technology.

    In the recent past, physicians and health care providers were likely to practice defensive medicine to avoid litigious complications. This practice led to unnecessary and expensive diagnostic procedures. While the introduction of managed care has impacted that to some extent, there are some out there, physicians included, who claim that managed care has gone too far and has resulted in denying necessary treatments or diagnostics to patients.

    Only through continual review by reliable organizations can the appropriate allocation of scarce resources be determined. These reviews will result in clinical guidelines and protocols on the appropriate uses of technology.
     

    Terms

    Technology Assessment Defined
    Relationship to Quality
    Categories of Technology (Devices, Procedures, Pharmaceuticals)
    Technology Life Cycle
    Factors for determining the use of technology
    Tools to assess technology and assessment problems
    Examples of agencies assessing technology
    Technology and Health Care Reform
    Be able to identify at least 2 technology devices from COMA Video
    What organization is likely to consider the procedure in COMA Video
    Major benefit of the procedure used in COMA Video